Catherine F. Li

发表

Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor)

N. Brünner, B. Alman, P. Nadesan, 2005, Oncogene.

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

Sabine Tejpar, Frans van Roy, Benjamin A Alman, 1999, Oncogene.

Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse

R. Y. Wei, S. Scherer, B. Alman, 2007, BMC Genomics.

Genetics of dermatofibrosarcoma protuberans family of tumors : from ring chromosomes to tyrosine kinase inhibitor treatment

J. Manna, Catherine F. Li, B. Berry, 2012 .

Potential Treatment for Clubfeet Based on Growth Factor Blockade

Benjamin A. Alman, B. Alman, W. Cole, 2001, Journal of pediatric orthopedics.

Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor)

Riccardo Fodde, Benjamin A Alman, B. Alman, 2001, Oncogene.

Smith–Lemli–Opitz Syndrome (SLOS) and the Fetus

J. Milunsky, Catherine F. Li, 2016, Journal of Fetal Medicine.

An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients

R. Y. Wei, B. Alman, B. Bapat, 2006, Familial Cancer.

Beta-catenin Mediates Soft Tissue Contracture in Clubfoot

B. Alman, R. Poon, Catherine F. Li, 2009, Clinical orthopaedics and related research.

Identification of Critical Region Responsible for Split Hand/Foot Malformation Type 3 (SHFM3) Phenotype through Systematic Review of Literature and Mapping of Breakpoints Using Microarray Data

J. Milunsky, Catherine F. Li, Katie Angione, 2015, Microarrays.

Adenomatous Polyposis Coli Gene Mutation Alters Proliferation through its β-Catenin-Regulatory Function in Aggressive Fibromatosis (Desmoid Tumor)

B. Alman, B. Bapat, C. Li, 1998 .